Nearly 3 weeks after Phase II lungcancer failure MerrimackPharma is scrapping MM121 and eliminating 60 of workforce httpow.lyh7zp30mxZkoÂ

Nearly 3 weeks after Phase II #lungcancer failure, @MerrimackPharma is scrapping MM-121 and eliminating 60% of workforce: http://ow.ly/h7zp30mxZko 

16:55 EST 8 Nov 2018 | Genetic Engineering News

Nearly 3 weeks after Phase II #lungcancer failure, @MerrimackPharma is scrapping MM-121 and eliminating 60% of workforce: http://ow.ly/h7zp30mxZko 

More From BioPortfolio on "Nearly 3 weeks after Phase II #lungcancer failure, @MerrimackPharma is scrapping MM-121 and eliminating 60% of workforce: http://ow.ly/h7zp30mxZko "